Integrated analysis of single-cell and bulk RNA sequencing identifies a signature based on macrophage marker genes involved in prostate cancer prognosis and treatment responsiveness

前列腺癌 接收机工作特性 肿瘤科 生物 弗雷明翰风险评分 比例危险模型 癌症 内科学 多西紫杉醇 肿瘤微环境 免疫系统 医学 免疫学 疾病
作者
Xiugai Li,Chang Zheng,Xiaoxia Xue,Junying Wu,Fei Li,Dan Song,Xuelian Li
出处
期刊:Functional & Integrative Genomics [Springer Science+Business Media]
卷期号:23 (2) 被引量:3
标识
DOI:10.1007/s10142-023-01037-9
摘要

In the tumor microenvironment, tumor-associated macrophages (TAMs) interact with cancer cells and contribute to the progression of solid tumors. Nonetheless, the clinical significance of TAM-related biomarkers in prostate cancer (PCa) is largely unexplored. The present study aimed to construct a macrophage-related signature (MRS) for predicting PCa patient prognosis based on macrophage marker genes. Six cohorts comprising 1056 PCa patients with RNA-Seq and follow-up data were enrolled. Based on macrophage marker genes identified by single-cell RNA-sequencing (scRNA-seq) analysis, univariate analysis, least absolute shrinkage and selection operator (Lasso)-Cox regression, and machine learning procedures were performed to derive a consensus MRS. Receiver operating characteristic curve (ROC), concordance index, and decision curve analyses were used to confirm the predictive capacity of the MRS. The predictive performance of the MRS for recurrence-free survival (RFS) was stable and robust, and the MRS outperformed traditional clinical variables. Furthermore, high-MRS-score patients presented abundant macrophage infiltration and high-expression levels of immune checkpoints (CTLA4, HAVCR2, and CD86). The frequency of mutations was relatively high in the high-MRS-score subgroup. However, the low-MRS-score patients had a better response to immune checkpoint blockade (ICB) and leuprolide-based adjuvant chemotherapy. Notably, abnormal ATF3 expression may be associated with docetaxel and cabazitaxel resistance in PCa cells, T stage, and the Gleason score. In this study, a novel MRS was first developed and validated to accurately predict patient survival outcomes, evaluate immune characteristics, infer therapeutic benefits, and provide an auxiliary tool for personalized therapy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
乐乐应助健忘英姑采纳,获得10
2秒前
嗯嗯发布了新的文献求助10
2秒前
3秒前
Wangyicong完成签到,获得积分10
4秒前
Lucas应助科研通管家采纳,获得10
5秒前
萧水白应助科研通管家采纳,获得10
5秒前
Lucas应助科研通管家采纳,获得10
5秒前
田様应助科研通管家采纳,获得10
5秒前
大模型应助科研通管家采纳,获得10
5秒前
大模型应助科研通管家采纳,获得10
5秒前
bkagyin应助科研通管家采纳,获得30
5秒前
科研通AI2S应助科研通管家采纳,获得10
5秒前
FashionBoy应助科研通管家采纳,获得10
5秒前
5秒前
5秒前
萧水白应助科研通管家采纳,获得10
5秒前
5秒前
5秒前
5秒前
阿腾发布了新的文献求助10
6秒前
FloppyWow完成签到 ,获得积分10
7秒前
xn201120发布了新的文献求助150
7秒前
舒心的依风完成签到,获得积分10
8秒前
嗯嗯完成签到,获得积分10
9秒前
baba发布了新的文献求助10
10秒前
胡庆余堂小洋参完成签到,获得积分10
10秒前
Akim应助义气萝卜头采纳,获得10
12秒前
眼睛大寻双完成签到,获得积分20
13秒前
Orange应助兴奋雁蓉采纳,获得10
14秒前
猪猪hero应助ElbingX采纳,获得20
16秒前
17秒前
17秒前
18秒前
好旺完成签到,获得积分10
21秒前
CC关闭了CC文献求助
21秒前
深情安青应助霸气安筠采纳,获得20
22秒前
思源应助htx采纳,获得30
22秒前
思源应助苏苏苏only采纳,获得10
23秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3976267
求助须知:如何正确求助?哪些是违规求助? 3520472
关于积分的说明 11203425
捐赠科研通 3257089
什么是DOI,文献DOI怎么找? 1798589
邀请新用户注册赠送积分活动 877785
科研通“疑难数据库(出版商)”最低求助积分说明 806523